Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Hold
1,868
0.03% 48
2026
Q1
$216K Hold
1,868
0.03% 50
2025
Q4
$204K Buy
+1,868
New +$175K 0.03% 51
2024
Q4
Sell
-2,039
Closed -$221K 46
2024
Q3
$221K Hold
2,039
0.04% 42
2024
Q2
$258K Buy
2,039
+67
+3% +$8.63K 0.05% 38
2024
Q1
$252K Buy
1,972
+94
+5% +$11.6K 0.05% 36
2023
Q4
$220K Buy
+1,878
New +$195K 0.05% 34

Other funds holding MRK

Crane Advisory's MRK Position: Q2 2026 in Review

Crane Advisory held its Merck (MRK) position steady in Q2 2026 at 1,868 shares worth $238K. The position accounts for 0.03% of the portfolio, ranked #48.

Crane Advisory first reported a position in MRK in Q4 2023 and has held it in 7 quarters since. The position peaked at $258K in Q2 2024. 1,580 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Crane Advisory held 1,868 shares of Merck worth $238K as of Q2 2026.
  • Crane Advisory left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.03% of Crane Advisory's portfolio in Q2 2026, its #48 holding.
  • Crane Advisory first reported a position in Merck in Q4 2023 and has held it in 7 quarters since.
  • Crane Advisory's Merck position peaked at $258K in Q2 2024.
  • 1,580 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Crane Advisory's 13F filing for Q2 2026, filed 20 Jul 2026.